Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 102 results for "first pharma"

Glenmark Pharma begins clinical trial of anti-myeloma drug

Glenmark Pharma today said the first patient has been dosed in a phase-1 clinical trial of GBR 1342, an investigational antibody for treatment of multiple myeloma.In May this year, the US health regulator had cleared Glenmark Pharma's investigational new drug ... Business Standard, 1 week ago

50 images for first pharma

Business Standard, 3 days ago
Business Standard, 4 days ago
Business Standard, 3 days ago
Business Standard, 5 days ago
Business Standard, 3 days ago
Business Standard, 4 days ago
Business Standard, 6 days ago
Business Standard, 6 days ago
Business Standard, 2 weeks ago
Business Standard, 2 weeks ago
Money Control

Short PNB, Can Fin Homes, Capital First; buy Hero MotoCorp, Ajanta Pharma: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com is of the view that one can sell PNB, Can Fin Homes and Capital First and can buy Hero MotoCorp and Ajanta Pharma.
 Money Control1 month ago

Closing bell: Sensex ends up 112 pts, Nifty ends above 10,450 for first time

BHEL, Axis Bank and Tata Power gained the most on both indices, while Sun Pharma, BPCL and Coal India were the top losers.  
 Money Control1 month ago
Money Control

#39;Pharma exports declined by 4% up to August on pricing pressure#39

Pharma exports from India registered a negative growth of 4 percent during the first five months of the current fiscal owing to increased regulatory issues coupled with pricing pressure in global markets.
 Money Control2 months ago

Canadian police probe mysterious deaths of billionaire pharma couple | Reuters

The post Canadian police probe mysterious deaths of billionaire pharma couple | Reuters appeared first on Firstpost .
 First Post.com1 day ago
Business Standard

No major respite for Sun Pharma

The Sun Pharmaceutical stock, after seeing some gains post September quarter results, is now marginally below pre-result levels despite the recent positive news flow. So, what's keeping sentiment low in the counter?First the positive part. The latest ...
 Business Standard1 week ago World Stocks Positive as US Fed Looks to Raise Rates  Equitymaster.com3 weeks ago Market Outlook: Equity indices to take cues from results, macro-data  Sify1 month ago Strong US Markets; ITC, Tata Steel Results & Other Top Cues to Sway the Market Today  Equitymaster.com1 month ago

Glenmark Pharmaceuticals enters Respiratory Generic segment

Glenmark had entered into a Strategic Development & Licensing Agreement with Celon Pharma S.A. (Celon) to develop and market a generic version of GlaxoSmithKline's Seretide Accuhaler product - Fluticasone / Salmeterol dry powder Inhaler in Europe. This is the ...
 Business Standard2 weeks ago
Business Standard

Glenmark Pharma gets approval for inhaler product in Nordic countries

Glenmark Pharmaceuticals Europe Ltd today said it has received approval for an inhaled respiratory product in Nordic countries, including Sweden, Denmark, Norway, Finland and Iceland.The company "has successfully closed the decentralised registration ...
 Business Standard2 weeks ago

How desi brothers built a $1.8 bn drug co

Amneal Pharmaceuticals is set to pip Sun Pharma as the fifth largest generics maker in the US, reports Sohini Das. Illustration: Dominic Xavier/Rediff.com. Two Indian-American brothers hailing from Gujarat, Chirag and Chintu Patel, have built a $1.8-billion drug major Amneal Pharmaceuticals in the US from scratch in around a decade and a half. After its recent merger with Impax Laboratories last month, the combined entity, with revenues of $1.75-1.85 billion, is close to pipping Indian giant ...
 Rediff.com2 weeks ago
Sify

Natco's partner Alvogen gets nod for influenza drug in US

Natco Pharma today said its marketing partner Alvogen has received final approval to market oseltamivir phosphate powder used for the treatment of influenza in the US."Alvogen has received final approval and is the first to market generic equivalent to ...
 Business Standard1 month ago FDA nod to Natco's marketing partner Mylan for generic  Business Standard2 months ago Natco Pharma hits the roof after getting USFDA nod for Copaxone  Sify2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less